Corrigendum: Case report:

MAP2K1 MEK colorectal cancer panitumumab resistance mechanisms

Journal

Frontiers in oncology
ISSN: 2234-943X
Titre abrégé: Front Oncol
Pays: Switzerland
ID NLM: 101568867

Informations de publication

Date de publication:
2023
Historique:
received: 18 01 2023
accepted: 07 03 2023
medline: 15 4 2023
entrez: 14 4 2023
pubmed: 15 4 2023
Statut: epublish

Résumé

[This corrects the article DOI: 10.3389/fonc.2022.1030232.].

Identifiants

DOI: 10.3389/fonc.2023.1147497 PMID: 37056342 PMC: PMC10086435
pubmed: 37056342
doi: 10.3389/fonc.2023.1147497
pmc: PMC10086435
doi:

Types de publication

Published Erratum

Langues

eng

Pagination

1147497

Commentaires et corrections

Type : ErratumFor

Informations de copyright

Copyright © 2023 Mauri, Patelli, Gori, Lauricella, Mussolin, Amatu, Bencardino, Tosi, Bonazzina, Bonoldi, Bardelli, Siena and Sartore-Bianchi.

Auteurs

Gianluca Mauri (G)

Department of Oncology and Hemato-Oncology, Università degli Studi di Milano, Milan, Italy.
IFOM, Istituto Fondazione di Oncologia Molecolare ETS, Milan, Italy.
Department of Hematology, Oncology, and Molecular Medicine, Grande Ospedale Metropolitano Niguarda, Milan, Italy.

Giorgio Patelli (G)

Department of Oncology and Hemato-Oncology, Università degli Studi di Milano, Milan, Italy.
Department of Hematology, Oncology, and Molecular Medicine, Grande Ospedale Metropolitano Niguarda, Milan, Italy.

Viviana Gori (V)

Department of Oncology and Hemato-Oncology, Università degli Studi di Milano, Milan, Italy.
Department of Hematology, Oncology, and Molecular Medicine, Grande Ospedale Metropolitano Niguarda, Milan, Italy.

Calogero Lauricella (C)

Department of Hematology, Oncology, and Molecular Medicine, Grande Ospedale Metropolitano Niguarda, Milan, Italy.

Benedetta Mussolin (B)

Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Torino, Italy.

Alessio Amatu (A)

Department of Hematology, Oncology, and Molecular Medicine, Grande Ospedale Metropolitano Niguarda, Milan, Italy.

Katia Bencardino (K)

Department of Hematology, Oncology, and Molecular Medicine, Grande Ospedale Metropolitano Niguarda, Milan, Italy.

Federica Tosi (F)

Department of Hematology, Oncology, and Molecular Medicine, Grande Ospedale Metropolitano Niguarda, Milan, Italy.

Erica Bonazzina (E)

Department of Hematology, Oncology, and Molecular Medicine, Grande Ospedale Metropolitano Niguarda, Milan, Italy.

Emanuela Bonoldi (E)

Department of Hematology, Oncology, and Molecular Medicine, Grande Ospedale Metropolitano Niguarda, Milan, Italy.

Alberto Bardelli (A)

Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Torino, Italy.
Department of Oncology, Università degli Studi di Torino, Turin, Italy.

Salvatore Siena (S)

Department of Oncology and Hemato-Oncology, Università degli Studi di Milano, Milan, Italy.
Department of Hematology, Oncology, and Molecular Medicine, Grande Ospedale Metropolitano Niguarda, Milan, Italy.

Andrea Sartore-Bianchi (A)

Department of Oncology and Hemato-Oncology, Università degli Studi di Milano, Milan, Italy.
Department of Hematology, Oncology, and Molecular Medicine, Grande Ospedale Metropolitano Niguarda, Milan, Italy.

Classifications MeSH